Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(578/week)
Manufacturing
(398/week)
Energy
(304/week)
Technology
(413/week)
Environment
(238/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Mirati Therapeutics, Inc.
Feb 18, 2021
Mirati Therapeutics To Present At Upcoming Healthcare Conferences
Feb 10, 2021
MD Anderson And Mirati Therapeutics Announce KRAS Strategic Research And Development Collaboration In Solid Tumors
Feb 04, 2021
Mirati Therapeutics To Present At Guggenheim Healthcare Talks 2021 Oncology Days
Nov 23, 2020
Mirati Therapeutics To Participate In The 2020 Evercore ISI HealthCONx Conference
Nov 05, 2020
Mirati Therapeutics To Participate In The 29th Annual Credit Suisse Virtual Healthcare Conference
Oct 30, 2020
Mirati Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares
Oct 25, 2020
Mirati Therapeutics Reports Investigational Adagrasib (MRTX849) Preliminary Data Demonstrating Tolerability and Durable Anti-Tumor Activity as well as Initial MRTX1133 Preclinical Data
Oct 15, 2020
Mirati Therapeutics To Present Data During The 2020 EORTC-NCI-AACR International Virtual Conference On Molecular Targets And Therapeutics (ENA)
Sep 18, 2020
Mirati Therapeutics Presents Phase 2 Data On Sitravatinib In Combination With Nivolumab In Urothelial Cancer At ESMO Virtual Congress
Sep 17, 2020
Boehringer Ingelheim And Mirati Therapeutics Announce Clinical Collaboration To Study BI 1701963, A SOS1::pan-KRAS Inhibitor In Combination With MRTX849, A KRAS G12C Selective Inhibitor
Sep 03, 2020
Mirati Therapeutics To Participate In Citi's 15th Annual Biopharma Virtual Conference
Aug 13, 2020
Strata Oncology Announces Partnership to Broaden Enrollment in Mirati Therapeutics' Clinical Trial of MRTX849, a Novel KRAS G12C Selective Inhibitor
Aug 06, 2020
Mirati Therapeutics Reports Second Quarter 2020 Financial Results And Recent Business Highlights
Jun 05, 2020
Mirati Therapeutics to Present at 41st Annual Goldman Sachs Global Healthcare Conference
May 15, 2020
Mirati Therapeutics To Present Preclinical Data From Investigational Pipeline Of Novel Therapeutics At 2020 American Association For Cancer Research Virtual Annual Meeting II
May 07, 2020
Mirati Therapeutics Reports First Quarter 2020 Financial Results And Recent Corporate Updates
Feb 25, 2020
Mirati Therapeutics Reports Year-End 2019 Financial Results And Recent Corporate Updates
Feb 15, 2020
Mirati Therapeutics Announces Initial Data In Renal Cell Carcinoma From Ongoing Investigator Sponsored Clinical Trial Of Sitravatinib In Combination With Nivolumab At The 2020 ASCO Genitourinary Cancers Syposium
Jan 14, 2020
Mirati Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares
Jan 09, 2020
Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock
Page 1
››
Latest News
Apr 25, 2024
Global Partners Declares First-Quarter 2024 Cash Distribution of $0.7100 on Common Units
Apr 25, 2024
ChargePoint Releases an Enhanced Integrated Charging Experience for Fleets En-Route and At Home
Apr 25, 2024
Geopark Announces First Quarter 2024 Operational Update
Apr 25, 2024
The Spaceport Company Signs Agreement with Maritime Launch to Provide Tracking and Telemetry Stations for...
Apr 25, 2024
Intevac Announces First Quarter 2024 Financial Results
Apr 25, 2024
Expro Group Holdings N.V. Announces First Quarter 2024 Results
Apr 25, 2024
Laser Photonics’ Laser Technology Meets Unique Cleaning Needs of Precision Optics Manufacturers
Apr 25, 2024
LiveWire Group, Inc. Reports 2024 First Quarter Financial Results
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events